Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients

Diabetes

Volumn 46, Issue 6, 1997, Pages 1040-1046

  Avogaro, Angelo ^a   Piarulli, Francesco ^a   Valerio, Anna ^a   Miola, Marina ^a   Calveri, Massimo ^a   Pavan, Paola ^a   Vicini, Paolo ^a   Cobelli, Claudio ^a   Tiengo, Antonio ^a   Calò, Lorenzo ^a   Del Prato, Stefano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUCOSE; INSULIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FOREARM BLOOD FLOW; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VASODILATATION;

EID: 0030953203     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.6.1040     Document Type: Article

References (45)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 286:373-376, 1980
2. Vallance P, Collier J, Moncada S: Effects of endothelial-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000, 1989
3. AcVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR: Impaired endothelium-dependent and independent vasodilatation in patients with type II (noninsulin-dependent) diabetes mellitus. Diabetologia 35:771-776, 1992
4. McVeigh GE, Brennan GM, Hayes JR, Johnston GD: Primary nitrate tolerance in diabetes mellitus. Diabetotogia 37:115-117, 1994
5. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 (Suppl. V):67-76, 1993
6. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991
7. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
8. King GL, Shiba T, Oliver J, Inoguchi T, Bursell SE: Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annv. Rev Med 45:179-188, 1994
9. Meraji S, Jayakoby L, Senaratne MP, Thompson AB, Kappagoda T: Endothelium-dependent relaxation in aorta of diabetic rats. Diabetes 36:978-981, 1987
10. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk for atherosclerosis. Lancet 340: 1111-1115, 1992
11. Panza, JA, Casino PR, Kilcoyne CM, Quyyumi AA: Role of endothelium- derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87:1468-1474, 1993
12. Baron AD, Laakso M, Brechtel G, Edelman SV: Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin- dependent diabetic subjects: effects of insulin therapy. J Clin Invest 87:1186-1194, 1991
13. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994
14. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515, 1994
15. Feldman RD, Hramiak IM, Finegood DT, Behme MT: Parallel regulation of the local vascular and systemic metabolic effects of insulin. J Clin Endocrinol Metab 80:1556-1559, 1995
16. Beks PJ, Mackaay AJC, de Neeling JND, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoom study. Diabetologia 38:86-96, 1995
17. Rose G, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods. 2nd ed. Geneva, World Health Org., 1982
18. Avogaro A, Vicini P, Valerio A, Caumo A, Cobelli C: The hot but not the cold minimal model allows precise assessment of insulin sensitivity in MID DM subjects. Am J Physiol 270:E532-E540, 1996
19. Calabrò A, Piarulli F, Milan D, Rossi A, Coscetti G, Crepaldi G: Clinical assessment of low molecular weight heparin effects in peripheral vascular disease. Angiology 44:188-195, 1993
20. Avogaro A, Crepaldi C, Piarulli F, Milan D, Valerio A, Pavan P, Sacerdoti D, Calabrò A, Macdonald I, Crepaldi G, Scognamiglio R, Tiengo A: The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes 45:602-609, 1996
21. Kuzuya H, Blix PM, Horowitz DL, Steiner DF, Rubenstein AH: Determinations of free and total insulin and C-peptide in insulin treated diabetics. Diabetes 26:22-29, 1977
22. Cole RA, Soeldner JS, Dunn PJ, Bunn HF: A rapid determination of glycosylated hemoglobins using high-performance liquid chromatography. Metabolism 35:289, 1978
23. Lipid Research Clinics Program: Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. 2nd Ed. Washington, DC, U.S. Department of Health and Human Services, 1982
24. Roschlau VP, Bernt E, Gruber W: Enzymatische bestimmung des gesamtcholesterins im serum. Z Klin Chem Klin Biochem 12:403, 1974
25. Bucolog DH: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:475-482, 1973
26. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Quinci GB: Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38:51-61, 1981
27. 2]glucose kinetics. Diabetes 38:845-853, 1989
28. Calò L, Cantaro S, Calabrò A, Piarulli F, Rizzolo M, Favaro S, Antonello A, Crepaldi G, Borsatti A: Endothelium derived vasoactive substances in Bartter's syndrome. Angiology 46:905-913, 1995
29. - and cyclic GMP levels in patients with Bartter's syndrome: relationship to vascular reactivity. Am J Kidney Dis 27:784-789, 1996
30. Caumo A, Giacca A, Morgese C, Pozza G, Micossi P, Cobelli C: Minimal model of glucose disappearance: lessons from the labeled IVGTT. Diabet. Med 8:822-532, 1991
31. Del Prato S, Riccio A, Vigili de Kreutzenberg S, Dorella M, Tiengo A, DeFronzo RA: Basal plasma insulin levels exerts a qualitative but not quantitative effect on glucose-mediated glucose uptake. Am J Physiol 268:E1089-E1095, 1995
32. Morris SJ, Shore AC, Tooke JE: Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 38:1337-1344, 1995
33. Smits P, Kapma J, Jacobs MC, Lutterrnan J, Thien T: Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes 42:148-153, 1993
34. G-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-I: possible role of nitric oxide in muscle protein synthesis. J Clin Invest 97:1319-1328, 1996
35. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines. Diabetes 42:221-222, 1993
36. Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilatation in patients with non-insulin- dependent diabetes mellitus. J Clin Invest 97:22-28, 1996
37. Moreau P, Yamaguchi N, de Champlain J: Increased activity in the nitric oxide pathway during chronic euglycemic hyperinsulinemia in the rat. J Hypertens (Suppl. 5):S270-S271, 1993
38. Trovati M, Massucco P, Mattiello L, Cavalot F, Mularoni E, Hahn A, Anfossi G: Insulin increases cyclic nucleotide content in human vascular smooth muscle cell a mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetologia 8:936-941, 1995
39. Rubanyi L: Endothelium-derived relaxing and contracting factors. J Cell Biochem 46:27-36, 1991
40. Tesfamarian B, Jakubowski JA, Cohen RA: Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am J Physiol 257:H1327-H1333, 1989
41. O' Rouke ST, Vanhoutte PM: Vascular pharmacology. In Vascular Medicine: A Textbook of Vascular Biology and Diseases. Loscalzo J, Creager MA, Dzau VJ, Eds. Boston, Little, Brown, 1992, p. 133-155
42. Baron AD: Hemodynamic action of insulin. Am J Physiol 267:E187-E202, 1994
43. Bonadonna RC, Del Prato S, Saccomani MP, Bonora E, Gulli G, Ferrannini E, Bier DM, Cobelli C, De Fronzo RA: Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 92:486-494, 1993
44. Bonadonna R, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45:915-925, 1996
45. Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G: Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786-792, 1995